Rockefeller Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Rockefeller Capital Management's EDIT Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Editas Medicine (EDIT) stake by 4.3% in Q3 2026, selling an estimated $2.8K and leaving 21,508 shares worth $55.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3408.
Rockefeller Capital Management first reported a position in EDIT in Q4 2019 and has held it in 18 quarters since. The position peaked at $323K in Q3 2021. 219 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Rockefeller Capital Management held 21,508 shares of Editas Medicine worth $55.3K as of Q3 2026.
- Rockefeller Capital Management sold 957 Editas Medicine shares in Q3 2026, an estimated $2.8K.
- Editas Medicine made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3408 holding.
- Rockefeller Capital Management first reported a position in Editas Medicine in Q4 2019 and has held it in 18 quarters since.
- Rockefeller Capital Management's Editas Medicine position peaked at $323K in Q3 2021.
- 219 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.